Chemotherapy for the initial treatment of metastatic prostate adenocarcinoma and neuroendocrine carcinoma at diagnosis: real world application and impact in the SEER database (2004 –2018)

BACKGROUND: Randomized controlled phase III trials have reported significant improvements in disease response and survival with the addition of chemotherapy to androgen deprivation therapy for men presenting with metastatic prostate cancer. We examined the implementation of such knowledge and its im...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shihua, Yin, Ming, Wang, Peng, Folefac, Edmund, Monk, J. Paul, Tabung, Fred K., Clinton, Steven K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288985/
https://www.ncbi.nlm.nih.gov/pubmed/37361592
http://dx.doi.org/10.3389/fonc.2023.1165188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288985/
https://www.ncbi.nlm.nih.gov/pubmed/37361592
http://dx.doi.org/10.3389/fonc.2023.1165188

Ejemplares similares